ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,336,000 | +194.6% | 400,000 | +128.6% | 0.06% | +39.0% |
| Q4 2018 | $2,830,000 | -79.5% | 175,000 | -71.5% | 0.04% | -64.0% |
| Q1 2018 | $13,800,000 | -30.1% | 614,166 | -6.3% | 0.11% | -27.4% |
| Q4 2017 | $19,737,000 | +43.2% | 655,502 | +79.1% | 0.16% | +52.4% |
| Q3 2017 | $13,784,000 | +10.7% | 365,919 | -18.0% | 0.10% | -1.0% |
| Q2 2017 | $12,451,000 | -2.9% | 446,430 | +19.7% | 0.10% | 0.0% |
| Q1 2017 | $12,818,000 | – | 372,837 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |